Key Factor Supporting Artificial Intelligence In Cancer Diagnostics Market Development in 2025: Revolutionizing Cancer Care Artificial Intelligence Emerges As A Key Player In Advancing Cancer Diagnostics

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Artificial Intelligence In Cancer Diagnostics Market Size By 2025?
The market for artificial intelligence in cancer diagnostics has seen an explosive increase in size in the past few years. Its growth is predicted to continue, rising from $0.39 billion in 2024 to $0.52 billion in 2025 with a compound annual growth rate (CAGR) of 32.6%. Factors behind the growth during the historical period include an upsurge in cancer cases, access to extensive data, the emergence of personalized oncology, initiatives in precision medicine, and incorporation of genomic data.

How Big Is the Artificial Intelligence In Cancer Diagnostics Market Size Expected to Grow by 2029?
In the coming years, the market size of artificial intelligence in cancer diagnostics is projected to experience a remarkable surge, escalating to $1.55 billion by 2029 with a compound annual growth rate (CAGR) of 31.2%. This projected growth can be credited to factors such as clinician shortages, aging population, worldwide adoption of telemedicine, integration of AI with electronic health records, and the expansion of cancer screening programs. The forecast period is expected to see significant trends such as the rapid progress in AI algorithms, advancements in imaging technology, technological innovations in pathology, progress in radiomics and radiogenomics, drug development, deep learning, and AI's use in predictive biomarker discovery.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-cancer-diagnostics-global-market-report

Which Key Market Drivers Powering Artificial Intelligence In Cancer Diagnostics Market Expansion and Growth?
The increasing prevalence of cancer worldwide is predicted to surge the development of artificial intelligence for cancer diagnostic market in the upcoming period. Cancer is characterized by unregulated cell development affecting various organs, leading to substantial morbidity and mortality globally. Artificial intelligence is adopted in cancer diagnostic procedures to accurately and efficiently evaluate medical imaging data, leading to earlier identification and precise differentiation of cancerous cells. As an example, the World Health Organization, a Switzerland-based Intergovernmental organization, reported in February 2024, that around 20 million new cancer instances were documented in 2022, causing approximately 9.7 million fatalities. It is calculated that about 53.5 million people were still alive within a five-year span following a cancer diagnosis. Consequently, the increasing incidence of cancer is anticipated to substantially contribute to the development of the artificial intelligence sector in the cancer diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12685&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Artificial Intelligence In Cancer Diagnostics Market?
The rise of technology is seen as a critical trend gaining traction in the artificial intelligence (AI) division of the cancer diagnostics market. The primary focus of several major corporations in this market is to develop novel tools for a variety of cancer types to maintain their market standing. As an illustration, Qritive, an AI-powered solutions company from Singapore, launched QAi Prostate, a new AI-enabled instrument for diagnosing prostate cancer, in March 2023. QAi Prostate is proficient in accurately pinpointing prostatic adenocarcinoma areas and categorizing benign and malignant tumor regions in biopsy tissue samples. The tool provides an extensive summary of tumor size and proportion for each slide or region of interest (ROI), facilitating pathologists to swiftly make more insightful decisions.

What Are the Emerging Segments in the Artificial Intelligence In Cancer Diagnostics Market?
The artificial intelligence in cancer diagnostics market covered in this report is segmented -

1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types
3) By Application: Screening And Diagnosis, Tumor Identification, Surveillance, Treatment
4) By End-User: Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization

Subsegments:
1) By Software Solutions: Imaging Analysis Software, Predictive Analytics Software, Decision Support Systems, Data Management Platforms
2) By Hardware: Imaging Devices, Biomarkers Detection Equipment, Computing Infrastructure
3) By Services: Consulting Services, Implementation Services, Maintenance And Support Services, Training Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12685&type=smp

Who Are the Global Leaders in the Artificial Intelligence In Cancer Diagnostics Market?
Major companies operating in the artificial intelligence in cancer diagnostics market include Microsoft Corporation, Pfizer Inc., Johnson & Johnson's, Siemens, Roche Holding AG, Google LCC, International Business Machines Corporation, Thermo Fisher Scientific Inc., Oracle Corporation, GE Healthcare, Illumina Inc., Bio Rad Laboratories Inc., Flatiron Health, Tempus Labs Inc., Paige AI Inc., OncoHealth Corporation, Path AI Inc., Aidoc, Sophia Genetics SA, Digital Diagnostics Inc., Prognos Health, Aidence, Kheiron Medical Technologies Limited, Zebra Medical Vision, Niramai, Enlitic Inc., Therapixel, Medial EarlySign Ltd., Freenome, SkinVision B.V.

Which are the Top Profitable Regional Markets for the Artificial Intelligence In Cancer Diagnostics Industry?
North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12685

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.